Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant Bacillus Calmette–Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge
Fábio Mambelli, Fábio V. Marinho, Juvana Moreira Andrade, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 12, pp. 1925-1937
Open Access | Times Cited: 11

Showing 11 citing articles:

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil
Marco Antonio Moreira Puga, Roberto Dias de Oliveira, Patrícia Vieira da Silva, et al.
The Lancet Regional Health - Americas (2025) Vol. 44, pp. 101031-101031
Closed Access
Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
Petro Booysen, Katalin A. Wilkinson, Dylan Sheerin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
Sabrina Clever, Leonard Limpinsel, Christian Meyer zu Natrup, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 417-417
Open Access | Times Cited: 2
Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine
Bruno Vinícius Santos Valiate, Julia Castro, Tomás Gazzinelli Marçal, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110177-110177
Open Access | Times Cited: 2
Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections
Ana Carolina V. S. C. de Araujo, Fábio Mambelli, Rodrigo O. Sanches, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1386-1386
Open Access | Times Cited: 6
Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
Nicole L. Messina, Mariana G. Sperotto, Marco Antonio Moreira Puga, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity
Mario A. Ramírez, Ricardo A. Loaiza, Yohana Martínez-Balboa, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126203-126203
Closed Access | Times Cited: 1
Genetic engineering employing MPB70 and its promoter enables efficient secretion and expression of foreign antigen in bacillus Calmette Guérin (BCG) Tokyo
Atsuki Takeishi, Shaban A. Kaboso, Taichi Kakihana, et al.
Microbiology and Immunology (2024) Vol. 68, Iss. 4, pp. 130-147
Closed Access
Bacille-Calmette-Guerin modulates human macrophage and dendritic cell response to SARS-CoV-2 S-glycoprotein
Regina C. Ambe, Shubhang Bhalla, Alejandra Alvarado, et al.
Infectious Medicine (2023) Vol. 2, Iss. 3, pp. 241-245
Open Access | Times Cited: 1
Page 1

Scroll to top